Basel, 10 April 2017 Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer Second Phase III head-to-head study that showed that Alecensa helped people with advanced ALK-positive non-small cell lung cancer (NSCLC) Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared... Read more
Preliminary Findings Indicate Potential Efficacy of Cord Blood to Improve the Lives of Children with Social and Behavioral Challenges Associated with ASD WALTHAM, Mass. – April 5, 2017– Novel research results from Duke University’s Robertson Clinical and Translational Cell Therapy Program published today in the April issue of Stem Cells Translational Medicine indicate promising developments... Read more
New Cloud-Based PerkinElmer Signals™ Notebook Helps Scientists Accelerate Drug Discovery Research WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals™ Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition Booth #619 PerkinElmer’s new cloud-based Electronic Laboratory Notebook solution (ELN)... Read more
CHALFONT ST. GILES, UK and Nashville, Tennessee, USA – 3rd April 2017 – GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in Nashville, Tennessee, to provide both low energy (SPECT) and high energy (PET) radiopharmaceuticals to HealthTrust members across the United States. The agreement commenced on March 1, 2017. Marco... Read more
Biotransform solutions use the first commercial software to automate protein catabolite identification and speeds identification of metabolites and catabolites. March 29, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, announced today the latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution... Read more
Wauwatosa, Wisconsin – 13 March 2017 – Monitoring expectant mothers and their babies before and during childbirth is a vital and at times a complicated task. GE Healthcare is investing in innovations to make it easier. Today, GE Healthcare announced that it is expanding its Maternal-Infant Care business with the acquisition of Monica Healthcare, a... Read more
Radnor, PA – March 9, 2017 – VWR (NASDAQ: VWR), the leading global independent provider of products and service solutions to laboratory and production customers, is excited to announce an agreement with Avantor® Performance Materials, LLC. This agreement will allow VWR to distribute Avantor’s beaker-to-bulk portfolio of J.T.Baker® and Macron Fine Chemicals™ brand laboratory and... Read more
March 7, 2017 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, released its UNcle 2.0 software today. The new software turns the dial on UNcle all the way up to 11, adding 2 new applications to the 9 that were already... Read more
VIENNA, AUSTRIA – 1 March, 2017 – Growing its range of magnetic resonance imaging (MRI) contrast media options available to patients and radiologists, GE Healthcare today announced the launch of Clariscan™ (gadoteric acid) at the European Congress of Radiology (ECR) 2017 meeting. Clariscan is a gadolinium-based contrast agent (GBCA) designed to support effective visualisation of... Read more
CHALFONT ST. GILES, UK and GRAZ/WIEN, AUSTRIA – 7 February 2017 – The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize... Read more